These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 19193471

  • 1. The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells.
    Kodym E, Kodym R, Reis AE, Habib AA, Story MD, Saha D.
    Lung Cancer; 2009 Oct; 66(1):37-47. PubMed ID: 19193471
    [Abstract] [Full Text] [Related]

  • 2. The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines.
    Balcer-Kubiczek EK, Attarpour M, Edelman MJ.
    Cancer Chemother Pharmacol; 2007 May; 59(6):781-7. PubMed ID: 16957930
    [Abstract] [Full Text] [Related]

  • 3. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo.
    Grimes KR, Warren GW, Fang F, Xu Y, St Clair WH.
    Oncol Rep; 2006 Oct; 16(4):771-6. PubMed ID: 16969492
    [Abstract] [Full Text] [Related]

  • 4. SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples.
    Conroy A, Stockett DE, Walker D, Arkin MR, Hoch U, Fox JA, Hawtin RE.
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):723-32. PubMed ID: 19169685
    [Abstract] [Full Text] [Related]

  • 5. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
    Raju U, Ariga H, Koto M, Lu X, Pickett J, Valdecanas D, Mason KA, Milas L.
    Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of radiation sensitivity with BH3I-1 in non-small cell lung cancer.
    Roa W, Chen H, Alexander A, Gulavita S, Thng J, Sun XJ, Petruk K, Moore R.
    Clin Invest Med; 2005 Apr; 28(2):55-63. PubMed ID: 15909480
    [Abstract] [Full Text] [Related]

  • 7. AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells.
    Raghavan P, Tumati V, Yu L, Chan N, Tomimatsu N, Burma S, Bristow RG, Saha D.
    Int J Radiat Oncol Biol Phys; 2012 Nov 15; 84(4):e507-14. PubMed ID: 22795803
    [Abstract] [Full Text] [Related]

  • 8. Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.
    Koshimune R, Aoe M, Toyooka S, Hara F, Ouchida M, Tokumo M, Sano Y, Date H, Shimizu N.
    BMC Cancer; 2007 Jan 12; 7():8. PubMed ID: 17222343
    [Abstract] [Full Text] [Related]

  • 9. Radiosensitization of tumour cell lines by the polyphenol Gossypol results from depressed double-strand break repair and not from enhanced apoptosis.
    Kasten-Pisula U, Windhorst S, Dahm-Daphi J, Mayr G, Dikomey E.
    Radiother Oncol; 2007 Jun 12; 83(3):296-303. PubMed ID: 17521756
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sanyang Xuedai enhances the radiosensitivity of human non-small cell lung cancer cells via increasing iNOS/NO production.
    Wang L, Xia Y, Chen T, Zeng Y, Li L, Hou Y, Li W, Liu Z.
    Biomed Pharmacother; 2018 Jun 12; 102():618-625. PubMed ID: 29602129
    [Abstract] [Full Text] [Related]

  • 12. Enhanced lung cancer cell killing by the combination of selenium and ionizing radiation.
    Shin SH, Yoon MJ, Kim M, Kim JI, Lee SJ, Lee YS, Bae S.
    Oncol Rep; 2007 Jan 12; 17(1):209-16. PubMed ID: 17143500
    [Abstract] [Full Text] [Related]

  • 13. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
    Han Y, Wang Y, Xu HT, Yang LH, Wei Q, Liu Y, Zhang Y, Zhao Y, Dai SD, Miao Y, Yu JH, Zhang JY, Li G, Yuan XM, Wang EH.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):518-26. PubMed ID: 19735876
    [Abstract] [Full Text] [Related]

  • 14. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
    Hara T, Omura-Minamisawa M, Kang Y, Cheng C, Inoue T.
    Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1485-95. PubMed ID: 18640498
    [Abstract] [Full Text] [Related]

  • 15. Nimesulide, a selective COX-2 inhibitor, acts synergistically with ionizing radiation against A549 human lung cancer cells through the activation of caspase-8 and caspase-3.
    Kim BM, Won J, Maeng KA, Han YS, Yun YS, Hong SH.
    Int J Oncol; 2009 May 01; 34(5):1467-73. PubMed ID: 19360361
    [Abstract] [Full Text] [Related]

  • 16. Differential gene expression profiles of radioresistant non-small-cell lung cancer cell lines established by fractionated irradiation: tumor protein p53-inducible protein 3 confers sensitivity to ionizing radiation.
    Lee YS, Oh JH, Yoon S, Kwon MS, Song CW, Kim KH, Cho MJ, Mollah ML, Je YJ, Kim YD, Kim CD, Lee JH.
    Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):858-66. PubMed ID: 20510196
    [Abstract] [Full Text] [Related]

  • 17. Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.
    Albert JM, Cao C, Geng L, Leavitt L, Hallahan DE, Lu B.
    Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1536-43. PubMed ID: 16863930
    [Abstract] [Full Text] [Related]

  • 18. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
    Gan PP, Pasquier E, Kavallaris M.
    Cancer Res; 2007 Oct 01; 67(19):9356-63. PubMed ID: 17909044
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia-induced SM22α in A549 cells activates the IGF1R/PI3K/Akt pathway, conferring cellular resistance against chemo- and radiation therapy.
    Kim TR, Cho EW, Paik SG, Kim IG.
    FEBS Lett; 2012 Feb 17; 586(4):303-9. PubMed ID: 22245152
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
    Toulany M, Mihatsch J, Holler M, Chaachouay H, Rodemann HP.
    Radiother Oncol; 2014 May 17; 111(2):228-36. PubMed ID: 24857596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.